Health care professionals tend to be traditional and conservative when it comes to practice, so incorporating new technologies and innovations into the hospital and the operating room can be a challenge. Four cardiothoracic surgery change drivers — Shanda Blackmon, MD, MPH (Mayo Clinic), James Luketich, MD (UPMC Presbyterian), T. Sloan Guy, MD, MBA (Weill Cornell Medical Medicine), and Linda W. Martin, MD, MPH (University of Virginia) — provide advice on how to get buy-in from hospital administrators, as well as team members.

Image
Career Development Blog
Managing the transition from new surgeon to teacher
6 min read
Mara B. Antonoff, MD
Healthcare professionals tend to be traditional and conservative when it comes to practice, so incorporating new technologies and innovations into the hospital and the operating room can be a challenge.
12 min.
Two studies presented at an STS Annual Meeting showed that surgical therapy is superior to alternative treatment approaches for both esophageal cancer and coronary artery disease in younger patients.
16 min.

Two studies presented at the recent STS Annual Meeting showed that surgical therapy is superior to alternative treatment approaches for both esophageal cancer and coronary artery disease in younger patients. In light of these findings, Robbin G. Cohen, MD, MMM (University of Southern California), Mark S. Allen, MD (Mayo Clinic), Sebron W. Harrison, MD (Weill-Cornell Medicine), and Alan M.

On average, it takes 17 years before new innovation is disseminated into clinical practice. How can cardiothoracic surgery change that statistic and speed up the process?
12 min.

On average, it takes 17 years before new innovation is disseminated into clinical practice. How can cardiothoracic surgery change that statistic and speed up the process? Juan A. Sanchez, MD (St. Agnes HealthCare Baltimore) moderates a discussion with Michael S.

The volumes of two aortic valve replacements (AVR) procedures have changed dramatically over the past few years, with more transcatheter procedures now being performed than open surgical procedures. Four cardiac surgeons discuss the evolving trends in TAVR, why the changes are occurring, and what’s ahead for TAVR and SAVR. Wilson Y. Szeto, MD moderates the discussion that also features Michael J. Mack, MD, John V. Conte, MD, and Thomas E. MacGillivray, MD.

17 min.
Image
Career Development Blog
A key source of patients will be referrals, and those rely on strong communication with fellow physicians.
3 min read
V. Seenu Reddy, MD, MBA
Should patients remain active before, during, and after cardiac surgery? Some surgeons have opposing views.
15 min.

Should patients remain active before, during, and after cardiac surgery? Some surgeons have opposing views. Thomas G. Gleason, MD, from the University of Pittsburgh, and Edward P. Chen, MD, from Emory University, discuss the role of exercise in the treatment and recovery process following surgery for various forms of heart disease, especially among active patients.